Sectors:
Locations:
Min Investment:
Max Investment:
Target Investment:
Executive Program
Executive Program
Executive Program
2012
- Investing in industry defining technologies size 1997 - Healthtech, Human-Computer Interfaces, Quantum, Material Science, Autonomous Systems, Cybersecurity - Backing entrepreneurs from 5th generation funds; Over $1bn under management, >200 investments.
2022
2022
Synthetic reprogramming platform, to make new materials from drugs to electronics
2020
2020
V7 is turning the computer-vision workflow into the AI product, giving machines human-like visual cognition, and MLOps the ultimate tool.
2020
2020
Bringing imaging to companion diagnostics
2019
2019
Rethinking the delivery of cell and gene therapies
2014
2014
Organ preservation and transplantation
2016
2016
Natrox — Global standard in chronic wound healing
2020
2020
CUE1 is a non-invasive, discrete device relieving the symptoms of Parkinson’s.
2015
2015
Protein interference based phenotypic screening technology
2016
2016
Leading medical review platform for secondary care